Onco Wiki / drapeau rouge

Cancer colorrectal oligométastatique limité au foie (CRLM, métastases du foie colorrect...

Vue déterministe de l'entité source de la LJAM. L'autorité clinique demeure avec les ID de la source cités et l'état d'approbation de l ́examinateur.

IDRF-CRC-OLIGOMET-LIVER-DEFINITION
TypeSignal d’alerte
Étatreviewed 2026-05-08 | pending_clinical_signoff
MaladiesDIS-CRC
SourcesSRC-ESMO-COLON-2024 SRC-ESMO-CRC-2024 SRC-NCCN-COLON-2025

Origine du drapeau rouge

DéfinitionLiver-limited oligometastatic colorectal cancer (CRLM, colorectal liver metastases) — a distinct subset of stage IV CRC where intensified treatment with hepatic resection (or ablation) added to systemic chemo is potentially curative. Definition (per NCCN Colon v3.2025 + ESMO CRC 2024 + EORTC 40983 / Nordlinger 2008 trial framework): ≤5 liver metastatic lesions, all R0-resectable on multidisciplinary review, no extrahepatic disease, ECOG 0-1 fitness, controllable primary tumour. Triggers MDT (medical onc + hepatobiliary surgery + radiation onc + radiology) consideration of perioperative FOLFOX (or FOLFOXIRI in selected patients) + hepatic metastasectomy. Distinct from gastroesophageal OMEC-1 oligomet (RF-OLIGOMET-DEFINITION) — CRC oligomet uses ≤5 liver lesions (not ≤3 distant), restricts to liver only (extrahepatic excluded), and HER2-positive does NOT disqualify (anti-HER2 second-line...
Direction cliniqueintensifier
Catégoriehigh-risk-biology

Logique de déclenchement

{
  "all_of": [
    {
      "comparator": "<=",
      "finding": "liver_metastasis_count",
      "threshold": 5
    },
    {
      "finding": "all_liver_lesions_r0_resectable",
      "value": true
    },
    {
      "comparator": "<=",
      "finding": "ecog_performance_status",
      "threshold": 1
    },
    {
      "finding": "primary_tumor_controllable",
      "value": true
    }
  ],
  "none_of": [
    {
      "finding": "extrahepatic_metastasis",
      "value": true
    },
    {
      "finding": "peritoneal_carcinomatosis",
      "value": true
    }
  ],
  "type": "composite_score"
}

Notes

Liver-limited CRC oligometastatic criteria (basis: NCCN Colon v3.2025 "Resectable Synchronous Liver-Only Metastases" pathway + ESMO CRC 2024 + EORTC 40983 / Nordlinger Lancet 2008 trial framework): 1. ≤5 liver metastatic lesions (numerical threshold; some series extend to ≤7 with future-liver-remnant feasibility, but ≤5 is the conservative MDT cutoff used by NCCN/ESMO consensus). 2. All liver lesions R0-resectable on hepatobiliary surgical review, with adequate future liver remnant (≥30% in normal liver, ≥40% post-chemo, ≥50% in cirrhosis). 3. NO extrahepatic disease (lung mets, peritoneal carcinomatosis, extra-hepatic LN, distant LN beyond pericolic / mesorectal — all exclusions; if extrahepatic disease is also limited and resectable, treatment is individualised outside this RF and belongs to a future "CRC limited-met multi-organ" indication not in scope here). 4. ECOG 0-1 (fit for hepatectomy + perioperative chemo). 5. Controllable primary tumour (resected or resectable; no perforation / obstruction at the moment of intensification decision — RF-CRC-EMERGENCY-OBSTRUCTION-PERFORATION takes precedence and routes to emergency management first). CRC-specific differences from gastroe...

Utilisé par

Algorithmes

Chapitres du manuel

Indication